UKRI report reveals impact of COVID-19 research and innovation funding
The report highlights steps needed to ensure future pandemics are handled effectively
Read More
Author: Jen Brogan
UKRI’s MRC invests £2m for hard-to-treat cancers
Four research innovation teams are set to receive £500,000 each
Read More
Eisai launches new digital business company for dementia
Theoria technologies aims to empower those affected by dementia
Read More
Defibrillators should be given to high-risk heart failure patients sooner
Around 2.3 million people live with coronary heart disease in the UK
Read More
Salipro Biotech and Sumitomo Pharma collaborate for drug discovery
The research will aim to reveal the mechanism of action of a drug target candidate
Read More- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
